These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30261312)

  • 1. Structural diversity and flexibility of diabodies.
    Kwon NY; Kim Y; Lee JO
    Methods; 2019 Feb; 154():136-142. PubMed ID: 30261312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of mono- and bi-specific diabodies and reduction of their structural flexibility by introduction of disulfide bridges at the Fv interface.
    Kim JH; Song DH; Youn SJ; Kim JW; Cho G; Kim SC; Lee H; Jin MS; Lee JO
    Sci Rep; 2016 Sep; 6():34515. PubMed ID: 27682821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility.
    Carmichael JA; Power BE; Garrett TP; Yazaki PJ; Shively JE; Raubischek AA; Wu AM; Hudson PJ
    J Mol Biol; 2003 Feb; 326(2):341-51. PubMed ID: 12559905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
    Nielsen UB; Adams GP; Weiner LM; Marks JD
    Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of a diabody, a bivalent antibody fragment.
    Perisic O; Webb PA; Holliger P; Winter G; Williams RL
    Structure; 1994 Dec; 2(12):1217-26. PubMed ID: 7704531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics.
    Kipriyanov SM; Moldenhauer G; Schuhmacher J; Cochlovius B; Von der Lieth CW; Matys ER; Little M
    J Mol Biol; 1999 Oct; 293(1):41-56. PubMed ID: 10512714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
    Asano R; Kudo T; Nishimura Y; Makabe K; Hayashi H; Suzuki M; Tsumoto K; Kumagai I
    J Biochem; 2002 Dec; 132(6):903-9. PubMed ID: 12473192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-linking disulfide bonds govern solution structures of diabodies.
    Math BA; Waibl F; Lamp LM; Fernández-Quintero ML; Liedl KR
    Proteins; 2023 Sep; 91(9):1316-1328. PubMed ID: 37376973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro selection of bispecific diabody fragments using covalent bicistronic DNA display.
    Nakayama M; Komiya S; Fujiwara K; Horisawa K; Doi N
    Biochem Biophys Res Commun; 2016 Sep; 478(2):606-11. PubMed ID: 27473655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies.
    Kipriyanov SM; Moldenhauer G; Braunagel M; Reusch U; Cochlovius B; Le Gall F; Kouprianova OA; Von der Lieth CW; Little M
    J Mol Biol; 2003 Jun; 330(1):99-111. PubMed ID: 12818205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized linker sequences for the expression of monomeric and dimeric bispecific single-chain diabodies.
    Völkel T; Korn T; Bach M; Müller R; Kontermann RE
    Protein Eng; 2001 Oct; 14(10):815-23. PubMed ID: 11739902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody.
    Holliger P; Brissinck J; Williams RL; Thielemans K; Winter G
    Protein Eng; 1996 Mar; 9(3):299-305. PubMed ID: 8736497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput cytotoxicity and antigen-binding assay for screening small bispecific antibodies without purification.
    Sugiyama A; Umetsu M; Nakazawa H; Niide T; Asano R; Hattori T; Kumagai I
    J Biosci Bioeng; 2018 Aug; 126(2):153-161. PubMed ID: 29548844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfide-stabilized diabody antiCD19/antiCD3 exceeds its parental antibody in tumor-targeting activity.
    Wei L; Dongmei F; Ming Y; Ruizan S; Yan Y; Linlin J; Cihui Y; Shuangjing L; Min W; Jianxiang W; Dongsheng X
    Cell Oncol (Dordr); 2012 Dec; 35(6):423-34. PubMed ID: 23055339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved tumour targeting by disulphide stabilized diabodies expressed in Pichia pastoris.
    FitzGerald K; Holliger P; Winter G
    Protein Eng; 1997 Oct; 10(10):1221-5. PubMed ID: 9488147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Diabodies": small bivalent and bispecific antibody fragments.
    Holliger P; Prospero T; Winter G
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6444-8. PubMed ID: 8341653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabody.
    Lu D; Jimenez X; Witte L; Zhu Z
    Biochem Biophys Res Commun; 2004 May; 318(2):507-13. PubMed ID: 15120630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a diabody (small recombinant bispecific antibody) using a refolding system.
    Takemura S; Asano R; Tsumoto K; Ebara S; Sakurai N; Katayose Y; Kodama H; Yoshida H; Suzuki M; Imai K; Matsuno S; Kudo T; Kumagai I
    Protein Eng; 2000 Aug; 13(8):583-8. PubMed ID: 10964988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. scFv multimers of the anti-neuraminidase antibody NC10: length of the linker between VH and VL domains dictates precisely the transition between diabodies and triabodies.
    Atwell JL; Breheney KA; Lawrence LJ; McCoy AJ; Kortt AA; Hudson PJ
    Protein Eng; 1999 Jul; 12(7):597-604. PubMed ID: 10436086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeling domain interfaces to enhance heterodimer formation.
    Zhu Z; Presta LG; Zapata G; Carter P
    Protein Sci; 1997 Apr; 6(4):781-8. PubMed ID: 9098887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.